Alexion Pharma (Nasdaq: ALXN) announced the initiation of dosing in a single, multinational, placebo-controlled clinical trial to evaluate the efficacy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE